recent
risk
viral
infect
dramat
increas
owe
chang
human
ecolog
global
warm
increas
geograph
movement
peopl
good
howev
efficaci
vaccin
remedi
infecti
diseas
limit
high
mutat
rate
virus
especi
rna
virus
comprehens
review
effect
sever
probiot
paraprobiot
steril
probiot
prevent
treatment
virallyinduc
infecti
diseas
discuss
uniqu
role
agent
modul
crosstalk
commens
bacteria
mucos
immun
system
addit
provid
overview
uniqu
mechan
virus
elimin
stimul
type
interferon
product
probiot
paraprobiot
via
activ
dendrit
cell
although
detail
research
necessari
futur
probiot
andor
paraprobiot
expect
among
ration
adjunct
option
treatment
variou
viral
diseas
variou
strategi
use
vaccin
antibiot
exploit
prevent
treatment
infecti
diseas
infect
control
yet
achiev
suffici
level
addit
avian
influenza
sever
acut
respiratori
syndrom
ebola
hemorrhag
fever
mani
problemat
diseas
tropic
origin
remain
poorli
control
dengu
fever
zika
viru
infect
climat
chang
includ
global
warm
increas
geograph
movement
peopl
good
emerg
number
pathogen
viru
speci
affect
area
increas
therefor
risk
viral
infect
becom
critic
issu
repres
pathogen
viru
influenza
viru
sometim
undergo
process
discontinu
mutat
result
efficaci
vaccin
influenza
viru
may
becom
disrupt
phenomenon
sometim
caus
pandem
japan
first
case
zika
viru
infect
report
case
infect
dengu
viru
report
viru
absent
year
previous
addit
influenza
noroviru
infect
often
occur
season
progress
recent
immunolog
research
innat
immun
respons
subsequ
activ
acquir
immun
respons
recognit
elimin
virus
unveil
report
process
viral
elimin
larg
depend
induct
type
interferon
ifn
regul
inflammatori
cytokin
mediat
via
pattern
recognit
receptor
tolllik
receptor
retinoicacidinduc
gene
studi
begun
elucid
immunostimulatori
effect
lactic
acid
bacteria
report
capac
contribut
prevent
viral
address
correspond
author
depart
medicin
shiga
univers
medic
scienc
otsu
japan
email
kanauchio
kirincojp
infect
includ
influenza
well
treatment
helicobact
pylori
infect
discuss
follow
section
type
ifn
consid
pivot
mediat
protect
effect
lactic
acid
bacteria
infect
review
first
summar
recent
prevent
therapeut
strategi
infecti
diseas
special
emphasi
viral
infect
outlin
possibl
applic
sever
probiot
paraprobiot
prophylact
therapi
viral
infecti
diseas
basi
publish
clinic
trial
data
sinc
difficult
cite
studi
regard
effect
paraprobiot
probiot
viru
infecti
diseas
show
repres
studi
two
criteria
singl
probiot
paraprobiot
studi
human
clinic
trial
exclud
mixtur
strain
anim
studi
evalu
efficaci
viral
infecti
diseas
final
introduc
uniqu
topic
immun
defens
mechan
viral
infect
induc
probiot
paraprobiot
infecti
diseas
especi
nosocomi
infect
ie
influenza
pneumonia
methicillinresist
staphylococcu
aureu
noroviru
sever
acut
respiratori
syndrom
corona
viru
etc
period
caus
widespread
outbreak
consid
repres
seriou
threat
public
health
review
outlin
strategi
prevent
treatment
infect
upper
respiratori
gastrointestin
tract
repres
infecti
diseas
well
known
influenza
viru
rhinoviru
respiratori
syncyti
viru
play
major
role
upper
respiratori
tract
infect
urti
noroviru
rotaviru
also
import
caus
gastrointestin
diseas
gener
acknowledg
main
prophylact
measur
infecti
diseas
vaccin
everyday
send
order
reprint
reprint
benthamsciencea
hygien
behavior
gargl
handwash
nagatak
et
al
outlin
gargl
povidoneiodin
solut
effect
reduc
incid
episod
acut
respiratori
infect
sinc
colon
bacteria
destroy
gargl
heijn
et
al
report
enhanc
hygien
measur
includ
proper
hand
clean
use
soap
dispos
paper
towel
effect
limit
transmiss
noroviru
outbreak
although
vaccin
promis
prophylact
influenza
infect
efficaci
limit
frequent
fast
mutat
rna
virus
includ
influenza
viru
popular
influenza
treatment
regimen
includ
neuraminidas
inhibitor
ion
channel
protein
inhibitor
activ
prescrib
clinic
set
inhibitor
hemagglutinin
sialidas
nucleocapsid
protein
rnadepend
rna
polymeras
also
current
use
howev
develop
acquir
resist
current
antiinfluenza
drug
emerg
mutat
influenza
viru
continu
present
major
challeng
effect
treatment
influenza
noroviru
rotaviru
repres
gastrointestin
pathogen
highli
infecti
caus
sever
diarrhea
present
situat
without
effect
vaccin
medicin
prevent
viral
transmiss
must
reli
mainli
basic
measur
includ
quarantin
thorough
hand
wash
physic
contact
particular
rotaviru
resist
chlorin
alcohol
although
infect
prevent
wipe
contamin
site
ethanol
solut
contain
ophenylphenol
vaccin
neonat
also
conduct
shown
good
efficaci
noroviru
also
highli
contagi
resist
alcohol
contamin
site
recommend
wipe
bleach
contain
ppm
chlorin
vaccin
noroviru
current
develop
current
effect
treatment
either
viral
infect
thu
treatment
gener
recommend
prevent
dehydr
caus
diarrhea
vomit
maintain
suffici
fluid
intak
wait
viru
elimin
gastrointestin
tract
progress
research
relationship
microbiota
diseas
recent
year
commens
intestin
bacteria
investig
abil
modul
host
immun
system
healthi
individu
also
suffer
wide
rang
diseas
reveal
commens
bacteria
also
regul
regulatori
cell
type
innat
lymphoid
cell
helper
cell
recognit
bacteria
metabolitesproduct
immun
cell
greatli
affect
mucos
immun
probiot
act
innat
acquir
immun
system
potenc
decreas
sever
infect
gastrointestin
upper
respiratori
tract
probiot
defin
live
microorgan
health
benefit
host
gener
consum
compon
ferment
food
yoghurt
chees
pickl
supplement
recent
ghost
probiot
paraprobiot
report
retain
immunomodulatori
potenc
beyond
viabil
probiot
contain
immunostimulatori
substanc
lipoteicho
acid
peptidoglycan
nucleic
acid
tolllik
receptor
tlr
ligand
muramyl
dipeptid
nodlik
receptor
ligand
follow
section
focu
effect
probiot
includ
paraprobiot
viral
infect
particularli
discuss
repres
probiot
shown
uniqu
prevent
therapeut
potenc
viral
diseas
clinic
studi
tabl
lc
reduc
plasma
cytomegaloviru
epsteinbarr
viru
antibodi
titer
highli
physic
activ
peopl
univers
athlet
howev
signific
differ
incid
norovirusinduc
gastroenter
lc
control
group
longstay
elderli
peopl
health
servic
facil
although
effect
lc
remain
controversi
potenti
mechan
report
wherein
lc
found
modul
activ
natur
killer
nk
cell
one
firstlin
defens
mechan
viral
infect
prevent
effect
lgg
experiment
rhinoviru
infect
healthi
volunt
evalu
ingest
lgg
month
subject
intranas
inocul
rhinoviru
infect
rate
occurr
sever
cold
symptom
evalu
frequenc
sever
cold
symptom
number
subject
rhinoviru
infect
lgg
group
lower
control
group
although
differ
group
reach
signific
lgg
administ
week
children
gastroenter
posit
either
rotaviru
cryptosporidium
speci
stool
signific
increas
serum
immunoglobulin
ig
g
level
postintervent
observ
children
rotavirusinduc
diarrhea
receiv
lgg
among
children
cryptosporidi
diarrhea
receiv
lgg
show
signific
improv
intestin
permeabl
mechan
probiot
exert
immunomodulatori
effect
complet
understood
howev
lgg
demonstr
modul
innat
adapt
immun
respons
particularli
gastrointestin
pathogen
result
increas
level
serum
igg
secretori
iga
target
enter
pathogen
includ
rotaviru
studi
demonstr
consumpt
yoghurt
ferment
augment
nk
cell
activ
reduc
risk
catch
common
cold
elderli
individu
studi
show
secret
polysaccharid
improv
immun
system
function
accompani
activ
nk
cell
thu
product
might
contribut
prevent
respiratori
infect
caus
respiratori
influenza
virus
l
casei
report
potenc
shorten
durat
upper
respiratori
symptom
although
show
effect
immun
respons
influenza
vaccin
healthi
adult
anoth
studi
l
casei
demonstr
modul
immun
system
use
vaccin
model
healthi
subject
increas
baselin
titer
vaccinespecif
igg
plasma
well
vaccinespecif
secretori
iga
saliva
significantli
greater
probiot
group
compar
control
group
although
detail
studi
need
explor
comprehens
mechan
underli
immunomodulatori
antiinfecti
effect
l
casei
consid
probiot
stimul
innat
viral
defens
mechan
reduc
inflamm
host
nonviabl
show
signific
effect
immun
paramet
involv
respons
influenza
vaccin
elderli
peopl
immunosenesc
incid
acut
diarrhea
children
age
month
signific
reduct
incid
frequenc
diarrhea
incid
common
infecti
diseas
children
age
year
significantli
lower
incid
rate
common
infecti
diseas
group
lactobacillu
plantarum
upper
respiratori
tract
infect
bifidobacterium
animali
intestin
antibodi
respons
polioand
rotaviru
infant
healthi
week
fullterm
infant
prospect
studi
significantli
increas
fecal
antipolioviru
specif
iga
increas
antirotaviru
specif
iga
bifidobacterium
lacti
acut
rotaviru
diarrhea
children
month
year
hospit
diarrhea
rotaviru
sgnificantli
decreas
durat
period
diarrhea
lactococcu
lacti
l
lacti
plasma
pdc
acit
among
pbmc
symptom
common
cold
healthi
adult
l
lacti
jcm
activ
pdc
among
pbmc
significantli
reduc
risk
morbid
common
cold
influenzalik
ill
immunolog
respons
influenza
viru
healthi
adult
signific
decreas
cumul
incid
day
cough
feverish
signific
increas
antivir
factor
interferonstimul
gene
influenzalik
ill
immunolog
respons
influenza
viru
healthi
adult
signific
decreas
cumul
incid
day
sore
throat
cough
signific
increas
mrna
pbmc
antivir
immun
respons
physic
condit
healthi
adult
significantli
increas
pdc
activ
increas
mrna
express
signific
decreas
cumul
incid
day
coldlik
symptom
influenza
infect
school
children
signific
decreas
incid
rate
cumul
incid
rate
influenza
antivir
immun
respons
influenza
viru
signific
prevent
decreas
phagocyt
activ
neutrophil
common
cold
season
pedon
et
al
found
administr
reduc
incid
acut
diarrhea
healthi
children
age
month
incid
frequenc
diarrhea
significantli
reduc
supplement
compar
control
group
merenstein
et
al
report
could
reduc
incid
common
infecti
diseas
includ
diarrhea
children
age
year
attend
daycar
school
although
detail
mechan
still
unclear
previous
immunomodulatori
effect
heatkil
hk
evalu
result
show
hk
augment
innat
acquir
immun
respons
mice
human
subject
especi
view
product
type
ifn
interleukin
il
hiros
et
al
assess
effect
hk
intak
week
urti
symptom
immun
function
human
subject
experienc
high
level
psycholog
stress
incid
urti
significantli
lower
hk
group
control
group
addit
incid
urti
sever
durat
medic
show
signific
neg
correl
durat
hk
intak
percentag
chang
baselin
concanavalin
ainduc
prolifer
peripher
blood
mononuclear
cell
pbmc
significantli
greater
hk
group
control
group
although
serum
product
significantli
differ
group
oo
et
al
report
paraprobiot
enterococcu
faecali
strain
significantli
reduc
alanin
aminotransferas
alt
level
adult
hcvposit
subject
decreas
viral
load
although
detail
mechan
still
unclear
suggest
might
chang
microbiota
hcv
patient
play
role
decreas
alt
level
oral
administr
saccharomyc
boulardii
rehydr
significantli
shorten
durat
diarrhea
acut
rotaviru
gastroenter
children
bolivia
compar
control
rehydr
alon
detail
mechan
avail
investig
effect
infant
starter
formula
contain
probiot
bifidobacterium
animali
subspeci
lacti
intestin
immun
inflamm
sixweekold
healthi
fullterm
infant
enrol
prospect
studi
control
formula
control
cfu
g
head
week
antipoliovirusspecif
iga
antirotavirusspecif
iga
assess
significantli
increas
antipoliovirusspecif
iga
antirotavirusspecif
iga
although
show
tendenc
increas
p
turkey
et
al
report
bifidobacterium
lacti
oral
rehydr
treatment
significantli
shorten
diarrheal
period
acut
rotaviru
gastroenter
children
month
year
old
compar
control
oral
rehydr
alon
plasmacytoid
dendrit
cell
pdc
play
crucial
role
antivir
immun
product
larg
amount
ifn
l
lacti
found
activ
human
pdc
among
pbmc
healthi
volunt
especi
subgroup
volunt
origin
show
low
pdc
activ
also
significantli
attenu
cumul
common
cold
symptom
prophylact
effect
l
lacti
influenzalik
ill
healthi
volunt
winter
season
report
base
result
doubleblind
trial
administr
l
lacti
result
signific
decreas
cumul
number
day
incid
cough
feverish
defin
major
symptom
influenzalik
ill
compar
control
group
furthermor
pbmc
volunt
treat
l
lacti
jcm
cultur
inactiv
human
influenza
viru
express
show
higher
tendenc
interferonstimul
gene
significantli
elev
compar
control
group
result
suggest
intak
l
lacti
prevent
pathogenesi
influenzalik
ill
via
enhanc
respons
influenza
viru
two
separ
studi
express
mrna
level
pbmc
significantli
higher
group
treat
l
lacti
jcm
compar
correspond
control
group
addit
sakata
et
al
report
intak
yogurt
contain
l
lacti
jcm
significantli
reduc
cumul
incid
rate
influenza
among
schoolchildren
rural
area
japan
final
fujii
et
al
show
effect
oral
l
lacti
jcm
system
mucos
immunolog
paramet
healthi
volount
winter
common
cold
season
japan
continu
week
administr
l
lacti
jcm
significantli
reduc
cumul
day
symptom
sore
throat
compar
control
l
lacti
jcm
group
chang
secretori
iga
level
saliva
phagocyt
activ
neutrophil
significantli
lower
initi
level
placebo
group
although
could
reach
statist
differ
group
endpoint
propos
mechan
action
l
lacti
jcm
discuss
detail
next
section
dendrit
cell
dc
well
known
pivot
immun
cell
subset
link
innat
acquir
immun
respons
recogn
pathogen
endogen
inflammatori
signal
dendrit
cell
subdivid
pdc
myeloid
dc
mdc
dendrit
cell
among
pdc
rare
critic
subset
act
control
tower
viral
infect
detect
presenc
bacteria
virus
pdc
util
certain
tlr
especi
use
recognit
microbi
nucleic
acid
via
detect
unmethyl
cpg
motif
dna
recognit
microbi
rna
synthet
guanosin
analog
activ
pdc
tlr
ligand
bind
lead
product
type
ifn
type
ifn
famili
includ
serv
compon
firstlin
defens
infect
block
viral
replic
induct
type
ifn
mostli
associ
viral
infect
well
known
pathogen
bacteria
stimul
product
howev
nonpathogen
bacteria
includ
probiot
use
food
prepar
less
intens
studi
regard
abil
stimul
dcmediat
ifn
induct
describ
separ
detail
previous
screen
variou
lactic
acid
bacteria
abil
stimul
product
pdc
found
l
lacti
jcm
potent
stimul
type
ifn
product
stimulatori
effect
l
lacti
jcm
type
ifn
product
pdc
mdc
evalu
use
dc
deriv
murin
bone
marrow
obtain
sever
type
tlrknockout
mice
result
direct
activ
dc
l
lacti
jcm
major
type
type
ifn
ie
found
induc
effici
howev
product
complet
abolish
dendrit
cell
obtain
knockout
mice
thu
data
strongli
suggest
l
lacti
jcm
stimul
product
via
signal
furthermor
examin
whether
product
induc
cpg
dna
known
agonist
dna
extract
l
lacti
jcm
cpg
dna
dna
extract
l
lacti
jcm
strongli
induc
ifn
product
addit
l
lacti
jcm
observ
specif
taken
pdc
suggest
phagocytosi
play
import
role
activ
pdc
consequ
induc
product
ifn
product
pdc
synergist
elev
l
lacti
jcm
treatment
cocultur
mdc
therefor
crosstalk
direct
contact
mdc
pdc
consid
necessari
effect
induct
product
l
lacti
jcm
addit
l
lacti
jcm
stimul
express
immunoregulatori
receptor
icosl
pdc
accordingli
reinforc
induct
regulatori
cell
lethal
dose
parainfluenza
viru
inocul
intranas
mice
fed
l
lacti
surviv
rate
significantli
higher
control
group
surviv
l
lacti
jcm
surviv
control
group
day
inocul
intestin
pdc
mice
treat
l
lacti
jcm
type
ifn
express
significantli
elev
remark
prevent
effect
infiltr
neutrophil
lung
tissu
observ
signific
increas
express
gene
antivir
activ
includ
ifninduc
mrna
oligoadenyl
synthetaselik
radic
sadenosyl
methionin
domain
contain
observ
upon
treatment
l
lacti
jcm
although
lung
distantli
locat
contact
site
intestin
peyer
patch
l
lacti
jcm
stimul
local
pdc
lung
directli
oral
l
lacti
jcm
treatment
result
strong
resist
parainfluenza
viru
infect
vivo
well
known
play
import
role
antivir
immun
respons
induc
cytotox
activ
nk
cell
contribut
host
defens
viral
infect
inde
suzuki
et
al
report
l
lacti
activ
nk
cell
vitro
vivo
furthermor
effect
l
lacti
nk
cell
depend
upon
activ
dendrit
cell
among
number
activ
factor
nk
cell
includ
regard
one
effici
nk
cell
activ
factor
addit
report
product
virusstimul
pdc
markedli
increas
cytotox
activ
nk
cell
fig
although
discuss
direct
activ
pdc
l
lacti
jcm
plausibl
mechan
inhibit
viral
infect
underli
mechan
rule
inde
salminen
et
al
report
specif
probiot
bacteria
could
bind
inactiv
rotavirus
besid
direct
interact
virus
also
possibl
l
lacti
jcm
compet
viral
receptor
surfac
target
cell
produc
antimicrobi
potenti
antivir
substanc
stimul
hostcel
immun
defens
system
thu
futur
necessari
test
whether
l
lacti
jcm
also
directli
bind
inactiv
virus
sinc
result
data
could
provid
basi
novel
approach
inactiv
virus
reduc
risk
mucosaassoci
viral
infect
describ
efficaci
probiot
paraprobiot
prevent
treatment
infecti
diseas
increas
incid
recent
year
although
benefit
vaccin
antivir
drug
prevent
treatment
infecti
diseas
obviou
effect
hinder
larg
number
viral
speci
subtyp
well
high
mutat
rate
virus
sinc
virus
evolv
constantli
produc
serolog
divers
viral
popul
challeng
establish
effect
mean
protect
human
viral
infect
sever
clinic
report
regard
use
probiot
paraprobiot
prophylaxi
treatment
infecti
diseas
review
literatur
regard
sever
probiot
paraprobiot
agent
base
paper
describ
singl
paraprobiot
probiot
clinic
trial
avoid
crosstalk
mutual
interfer
probiot
agent
consid
safe
afford
easi
consum
long
histori
use
food
state
knowledg
regard
immunomodulatori
effect
probiot
recent
advanc
variou
studi
especi
focus
interact
commens
bacteria
mucos
immun
system
furthermor
role
type
ifn
elimin
pathogen
virus
involv
concert
activ
innat
acquir
immun
system
wide
studi
review
discuss
antiinfluenza
activ
l
lacti
jcm
potenc
directli
stimul
pdc
via
therebi
promot
viral
control
although
detail
research
necessari
probiot
andor
paraprobiot
expect
among
ration
adjunct
option
treatment
prophylaxi
viral
infect
applic
author
declar
conflict
interest
financi
otherwis
detect
presenc
bacteria
virus
pdc
util
certain
tolllik
receptor
tlr
famili
especi
use
recognit
microbi
nucleic
acid
detect
unmethyl
cpg
motif
dna
recognit
microbi
rna
synthet
guanosin
analog
activ
pdc
ligand
bind
tlr
lead
product
type
ifn
l
lacti
jcm
specif
taken
pdc
dna
extract
strongli
induc
ifn
product
observ
suggest
phagocytosi
l
lacti
jcm
pdc
play
import
role
activ
pdc
stimul
ifn
product
via
signal
play
import
role
mediat
antivir
immun
respons
induc
cytotox
activ
natur
killer
cell
contribut
host
defens
viral
infect
microscop
observ
human
pdc
stimul
l
lacti
also
shown
inset
pdc
stain
purpl
process
phagocytos
fluorescein
isothiocyanatestain
l
lacti
green
color
version
figur
avail
electron
copi
articl
